Lithotripsy Devices Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Type (Extracorporeal Shock Wave Lithotripsy Devices, Intracorporeal Lithotripsy Devices), By Application (Kidney Stones, Ureteral Stones, Pancreatic Stones, Bile Duct Stones), By End-User (Hospitals, Ambulatory Surgical Centers, Others), By Region and Competition, 2019-2029F

Market Overview

Global Lithotripsy Devices Market was valued at USD 1.21 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 4.76% through 2029.

Advancements in lithotripsy technology have played a significant role in driving market growth. Over the years, there have been notable improvements in lithotripsy devices, including the development of shock wave lithotripsy (SWL), intracorporeal lithotripsy techniques such as laser lithotripsy and ultrasound lithotripsy, and the introduction of more compact and user-friendly lithotripsy systems. These technological advancements have enhanced the efficiency, safety, and effectiveness of lithotripsy procedures, leading to better patient outcomes and higher treatment success rates. The increasing adoption of minimally invasive procedures in urology has fueled the demand for lithotripsy devices. Minimally invasive techniques offer several advantages over traditional surgical approaches, including shorter recovery times, reduced risk of complications, and improved patient comfort. Lithotripsy procedures typically involve less discomfort and shorter hospital stays compared to surgical interventions, making them more appealing to both patients and healthcare providers.

The global lithotripsy devices market encompasses a wide range of products and technologies tailored to meet the diverse needs of healthcare facilities and patients. Lithotripsy devices vary in terms of their mechanism of action, energy source, and mode of operation, allowing healthcare providers to choose the most suitable option based on factors such as patient anatomy, stone characteristics, and treatment preferences. Advancements in imaging technologies such as ultrasound and fluoroscopy have enabled more precise targeting of kidney stones during lithotripsy procedures, further improving treatment outcomes. The growing geriatric population worldwide is contributing to the increased prevalence of kidney stones and other urological conditions. Older adults are more susceptible to developing kidney stones due to age-related changes in kidney function and metabolism. As the elderly population continues to expand, there is a corresponding rise in the demand for lithotripsy procedures to manage urological conditions effectively. Additionally, the rising healthcare expenditure and increasing investments in healthcare infrastructure in emerging economies are expected to drive market growth by improving access to advanced lithotripsy technologies and enhancing healthcare delivery capabilities.

Key Market Drivers

Increasing Prevalence of Kidney Stones

The increasing prevalence of kidney stones serves as a critical market driver for the growth of the global lithotripsy devices market. Kidney stones are a common urological condition affecting people of all age groups and demographics. The incidence of kidney stones has been on the rise globally. While the exact reasons for this increase are multifactorial, dietary habits, sedentary lifestyles, and inadequate hydration play significant roles. High consumption of diets rich in salt, sugar, and processed foods, as well as reduced water intake, contributes to the formation of kidney stones. As these dietary and lifestyle patterns persist, the prevalence of kidney stones continues to grow, creating a larger patient pool in need of treatment.

The demographic composition of the global population is changing, with an increasing proportion of older individuals. Age is a significant risk factor for the development of kidney stones. As the world's population ages, there is a higher prevalence of kidney stones. This demographic shift has a direct impact on the market, as older individuals are more likely to require treatment for kidney stones. Obesity is another contributing factor to the increased prevalence of kidney stones. Obesity is associated with metabolic changes that can lead to the formation of kidney stones. As obesity rates continue to climb in various regions, the incidence of kidney stones follows suit. This connection between obesity and kidney stones further drives the demand for lithotripsy devices, as obese patients often require specialized treatment options.

Improved healthcare awareness and access to medical services have led to a higher diagnosis rate of kidney stones. Patients are more likely to seek medical attention when experiencing symptoms of kidney stones, which may include severe pain, hematuria (blood in the urine), and discomfort. Increased awareness and accessibility to healthcare services result in early diagnosis and treatment, further underscoring the demand for lithotripsy procedures and devices. The growing prevalence of kidney stones is not limited to developed nations but is also seen in many developing countries. As these regions improve their healthcare infrastructure and diagnostic capabilities, more cases of kidney stones are being identified. This expansion of the market in developing countries contributes significantly to the overall growth of the global lithotripsy devices market.

Increasing Preference for Minimally Invasive Treatments

The increasing preference for minimally invasive treatments is a substantial market driver contributing to the growth of the Global Lithotripsy Devices Market. This preference has gained momentum due to several factors that have reshaped the landscape of medical interventions, particularly for conditions like kidney stones.

Minimally invasive treatments, including lithotripsy, offer patients a significant advantage in terms of reduced discomfort and faster recovery. Unlike traditional surgical procedures, which involve large incisions and prolonged recovery periods, minimally invasive methods like lithotripsy involve smaller incisions or no incisions at all. Patients experience less pain, shorter hospital stays, and quicker return to their daily activities. Minimally invasive procedures typically result in lower complication rates compared to invasive surgical methods. With lithotripsy, the risk of infection, bleeding, and damage to surrounding tissues is minimized. This not only benefits patients by reducing the likelihood of post-operative complications but also saves healthcare resources that would otherwise be spent on managing complications.

Minimally invasive treatments can often be performed on an outpatient or ambulatory basis, reducing the burden on hospitals and allowing patients to return home shortly after the procedure. This shift in the treatment setting provides convenience for patients and reduces healthcare costs associated with prolonged hospital stays. Minimally invasive procedures like lithotripsy benefit from advanced imaging technologies. Real-time imaging, such as ultrasound or fluoroscopy, enables healthcare providers to visualize the stone and surrounding structures during the procedure. This precise imaging enhances the accuracy of stone targeting, reducing the risk of damage to healthy tissue and improving the overall effectiveness of the treatment.

Well-Established Healthcare Infrastructure and Reimbursement Support

The presence of a well-established healthcare infrastructure and reimbursement support is a crucial market driver for the growth of the Global Lithotripsy Devices Market. This driver is instrumental in creating an environment where healthcare providers can effectively offer lithotripsy treatments and patients can access and afford these services.

Well-established healthcare infrastructure means that regions with advanced facilities, hospitals, and specialized clinics are equipped to provide comprehensive urological care, including lithotripsy. These facilities are essential for the diagnosis, treatment, and post-operative care of kidney stone patients. Patients have confidence in receiving quality care in these settings, which drives the demand for lithotripsy services. A strong healthcare infrastructure also typically includes a well-trained and experienced healthcare workforce, including urologists, radiologists, and support staff. Healthcare professionals with expertise in lithotripsy ensure safe and effective treatments, further bolstering patient trust and demand.

Reimbursement support and insurance coverage play a pivotal role in making lithotripsy accessible to a broader patient population. When healthcare providers can bill for lithotripsy services and patients can rely on insurance coverage, the financial barrier to treatment is substantially reduced. This encourages more patients to consider lithotripsy as a viable treatment option. Reimbursement support and insurance coverage result in lower out-of-pocket expenses for patients. As lithotripsy procedures can be costly, this financial relief makes it more affordable for a wider range of individuals. Reduced out-of-pocket expenses increase patient compliance with medical recommendations, promoting timely lithotripsy procedures when necessary. A well-established healthcare infrastructure typically offers a variety of treatment settings, allowing patients to choose between outpatient and inpatient care. Outpatient lithotripsy is particularly attractive to patients, as it minimizes disruptions to their daily routines. Well-equipped outpatient facilities can perform lithotripsy procedures safely, thanks to the healthcare infrastructure's support.

Key Market Challenges

Cost Constraints

One of the primary challenges to the growth of the Global Lithotripsy Devices Market is the cost associated with these devices and procedures. Lithotripsy devices are often expensive, and the technology required for their operation can be financially burdensome for healthcare facilities. Additionally, the maintenance and servicing of these devices can also incur substantial costs. As a result, not all healthcare providers, especially those in resource-constrained settings or developing countries, can afford to invest in and maintain these devices. The high cost of lithotripsy can limit its availability and accessibility to a significant portion of the population.

Reimbursement Issues

While reimbursement support is a driver for market growth, it also presents challenges. The reimbursement landscape can be complex and varies from one region to another. In some cases, reimbursement rates may not fully cover the costs associated with lithotripsy procedures, leaving healthcare providers with financial losses. This can discourage healthcare facilities from offering these services or limit the number of procedures they are willing to perform. Inconsistencies in reimbursement policies and rates can create uncertainty for both healthcare providers and patients, slowing down the adoption of lithotripsy.

Key Market Trends

Technological Advancements

Technological innovations continue to drive the growth of the Global Lithotripsy Devices Market. Advancements in lithotripsy technology have resulted in more precise, efficient, and patient-friendly treatment options. Notable trends in technological advancements include

Patients can consult with healthcare providers remotely, allowing them to discuss treatment options, receive guidance, and schedule procedures, including lithotripsy. Lithotripsy devices equipped with remote monitoring capabilities enable healthcare providers to track patient progress and provide real-time support and adjustments. Telemedicine can bridge geographical gaps by connecting patients with specialized lithotripsy services that may not be locally found at. Mobile apps and online resources provide patients with information about kidney stones, lithotripsy, and post-procedure care.

Segmental Insights

Application Insight

Based on Application, the Kidney Stones emerged as the dominant segment in the global market for Lithotripsy Devices in 2023.

End-User Insights

Based on end-user, The hospitals segment is projected to experience rapid growth during the forecast period.

Hospitals frequently have specialized urology departments staffed with experienced urologists who are experts in managing urological conditions, including kidney stones. Urologists play a crucial role in determining the most suitable treatment method for each patient. Hospital pharmacies are well-equipped to support the needs of these departments by stocking lithotripsy devices and related supplies. Hospitals offer both inpatient and outpatient services, which makes them capable of providing various levels of care. Patients with different clinical presentations and severity of kidney stones can access treatment within the hospital setting. Hospital pharmacies play a pivotal role in ensuring the availability of lithotripsy devices and medications for both inpatient and outpatient procedures. These factors collectively contribute to the growth of this segment.

Regional Insights

Based on region, North America emerged as the dominant region in the global Lithotripsy Devices market in 2023, holding the largest market share in terms of value. The North American lithotripsy device market is poised for expansion due to several key factors. These include a rising prevalence of kidney stones, advancements in technology, a growing preference for minimally invasive treatments, a well-established healthcare infrastructure, increased healthcare spending, an aging population, strong reimbursement support, market competitiveness, and appeal to medical tourists. The competitive landscape in the North American medical device industry fosters innovation, leading to the introduction of cutting-edge lithotripsy devices. This provides healthcare providers with a wider array of choices and drives the market growth.

Recent Development

• In October2023, Shockwave Medical announced its intention to introduce the Shockwave C2+coronary intravascular lithotripsy (IVL) catheter in the United States,scheduled to debut at the Transcatheter Cardiovascular Therapeutics (TCT)annual scientific symposium in San Francisco from October 23 to 26. The companyhighlighted that the C2+ catheter offers 50% more pulses per catheter comparedto the previously released C2 version, which entered the US market followingapproval in 2021. Shockwave emphasizes that the C2+ catheter is currentlyavailable for commercial use in the treatment of de novo coronary arterydisease in the United States, Europe, and other selected markets.

Key Market Players

• Zimmer MedizinSysteme GmbH
• OlympusCorporation
• Richard WolfGmbH
• BostonScientific Corporation
• STORZ Medical AG